Ronald T. Piervincenzi, Ph.D.
Chief Executive Officer
Ronald T. Piervincenzi, Ph.D., is the new Chief Executive Officer of USP. He also serves as Chair of the Council of Experts, USP's scientific standards-setting body, which continuously revises standards in the United States Pharmacopeia–National Formulary, Medicines Compendium, USP Compounding Compendium, Herbal Medicines Compendium, Dietary Supplements Compendium, and Food Chemicals Codex.
For 12 years Dr. Piervincenzi was a partner and leader in McKinsey & Company's Global Pharmaceutical and Medical Products Practice where, among other responsibilities, he launched McKinsey's global drug safety, medical and regulatory service line. Most recently, as a VP in Development Sciences with Biogen Idec, he launched a new group (Value-Based Medicine) focused on applying tools and technologies of personalized medicine to the multiple sclerosis disease area.
Dr. Piervincenzi earned his M.S. and Ph.D. from Duke University in Biomedical Engineering, with research focused on protein engineering. He is the founder of multiple non-profits in the community service and scientific spaces including serving currently as Board Chair for the Newark Mentoring Movement and the NextStep Translational Research Foundation.